Brief: Chugai Pharmaceutical To Construct New Manufacturing Building For Active Pharmaceutical Ingredients For Clinical Studies
24/04/2019 09:01
April 24 (Reuters) - Chugai Pharmaceutical Co Ltd 4519.T :
* TO CONSTRUCT A NEW MANUFACTURING BUILDING FOR ACTIVE
PHARMACEUTICAL INGREDIENTS FOR CLINICAL STUDIES
* TOTAL INVESTMENT IS 18.2 BILLION YEN
Source text for Eikon: ID:nTSPX63fd8
Further company coverage: 4519.T
(Reporting By Chris Gallagher)
((chris.gallagher@thomsonreuters.com;))
Recent news on Chugai Pharmaceutical
See all newsRegarding Discontinuation Of Development Of Gym329 (Emugrobart) For Obesity, Return Of License And Resumption Of Development For SMA
Table: Chugai Pharm 6-MTH group results (IFRS)
Japan's Nikkei roars past 62,000 on earnings, Middle East optimism; JGBs rally (updated)
Japan's Nikkei surges past 61,000 for first time on earnings, Mideast optimism
Japan's Nikkei closes above 60,000 for first time on earnings optimism (updated)